# US 2020/0368027 A1 · Implantation Tool and Protocol for Optimized Solid Substrates Promoting Cell and Tissue Growth

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0368027 A1
- Document ID: US20200368027A1
- Status: Published application
- Kind: A1
- Application number: 16/959,447
- Filed: 2018-12-30
- Published: 2020-11-26
- Earliest claimed: 2018-01-02
- Assignees: Cartiheal (2009) Ltd.
- Applicants: Cartiheal (2009) Ltd.
- Inventors: Nir ALTSCHULER
- Web page: https://patentgrep.com/patent/US20200368027A1

## CPC

- A61F 2/30756: {Cartilage endoprostheses (A61F2/3603 takes precedence)}
- A61B 17/1604: {Chisels; Rongeurs; Punches; Stamps}
- A61B 17/1635: {for grafts, harvesting or transplants}
- A61F 2/4618: {of cartilage}
- A61B 17/1615: {Drill bits, i.e. rotating tools extending from a handpiece to contact the worked material}
- A61B 17/1659: {Surgical rasps, files, planes, or scrapers}
- A61B 17/17: Guides {or aligning means} for drills {, mills, pins or wires}
- A61B 17/1764: {for the knee}
- A61B 2017/0046: {with a releasable handle; with handle and operating part separable}
- A61F 2002/30214: {having tapered sections of different conicities}
- A61F 2002/30224: {cylindrical}
- A61F 2002/30253: {ellipsoidal or ovoid}
- A61F 2002/30593: {hollow}
- A61F 2002/30617: {Visible markings for adjusting, locating or measuring}
- A61F 2002/30759: {Mosaicplasty, i.e. using a plurality of individual cartilage plugs for filling a substantial cartilage defect}
- A61F 2002/30761: {Support means for artificial cartilage, e.g. cartilage defect covering membranes}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

This invention provides methods for optimal implantation of a solid substrate for promoting cell or tissue growth or restored function in an osteochondral, bone or cartilage tissue in a subject in need thereof. The methods include selecting and preparing a solid substrate for promoting cell or tissue growth or restored function for implantation, which solid substrate has a length and width or that promotes a tight fit within the boundaries of the implantation site and is further characterized by a height sufficient such that when a first terminus of said solid substrate is implanted within a bone in a site for implantation, a second terminus of said solid substrate is at a height at least 2 mm less than an articular cartilage layer surface or is proximal to a tide mark region in said implantation site and optionally applying a biocompatible polymer layer to an apical surface of said implant, which layer does not exceed the articular cartilage layer surface in height. Tools for implementation of optimal positioning are described including a unique tool (5-120) for trimming cartilage at the implantation site.

## Claims

### Claim 1

A method for optimal implantation of a solid substrate for promoting cell or tissue growth or restored function for the treatment of osteoarthritis, bone disorders, osteochondral defects, or cartilage lesions in a subject in need thereof, said method comprising:
selecting and preparing a solid substrate for the treatment of or promoting cell or tissue growth or restored function for stable implantation in a region traversing bone and cartilage in a subject, which solid substrate has a length and width or that promotes a tight fit within the boundaries of the implantation site and is further characterized by a height sufficient such that when a first terminus of said solid substrate is implanted within bone in a site for implantation, a second terminus of said solid substrate is at a height at least 2 mm less than an articular cartilage layer surface or proximal to a tide mark region in said implantation site;
implanting said selected and prepared solid substrate within a site for implantation to span a basal to apical long axis of said site for implantation, wherein a first terminus of said implant is implanted within bone at the basal surface and a second terminus is oriented apically such that said second terminus is at a height at least 2 mm less than an articular cartilage layer surface or is proximal to a tide mark region in said implantation site such that a void is formed between an apical surface of said substrate and an articular cartilage layer; wherein said site of implantation has been prepared for insertion of said solid substrate by creating a void of desired dimensions in terms of depth, length and width, and the side walls of the site for implantation have been created to contain a taper, and cartilage tissue within said site for implantation has been removed with the aid of the cartilage cutter, comprising:
an elongated handle;
a head region connected to said elongated handle, said head region further comprising
an apical portion which connects with said elongated handle;
a basal portion which inserts within an implantation site;
a first and second angled side regions, which taper from said apical portion toward said basal portion;
wherein said first angled side region further comprises:
a tapered blade surface,
a supporting tapered angled surface positioned opposingly to said tapered blade surface; and
a hollowed region located therebetween,
whereby tissue in contact with said tapered blade surface cut thereby is of a thickness accommodating insertion within said hollowed region, and optionally
applying a biocompatible polymer layer or hydrogel or therapeutic compound or cell population or combination thereof, to an apical surface of said implant to fill said void formed between said second terminus and said articular cartilage layer surface.

### Claim 2

A cartilage cutter, comprising:
an elongated handle;
a head region connected to said elongated handle, said head region further comprising
an apical portion which connects with said elongated handle;
a basal portion which inserts within an implantation site;
a first and second angled side regions, which taper from said apical portion toward said basal portion;
wherein said first angled side region further comprises:
a tapered blade surface,
a supporting tapered angled surface positioned opposingly to said tapered blade surface; and
a hollowed region located therebetween,
whereby tissue in contact with said tapered blade surface cut thereby is of a thickness accommodating insertion within said hollowed region.

### Claim 3 (depends on 2)

The cartilage cutter of claim 2, wherein said basal surface is substantially flat.

### Claim 4 (depends on 2)

The cartilage cutter of claim 2, wherein an interior region between said first and second angled side regions is substantially hollowed or wherein an interior region between said first and second angled side regions is substantially solid but contains a hollowed region into which the cut tissue may insert.

### Claim 5

(canceled)

### Claim 6 (depends on 2)

The cartilage cutter of claim 2, wherein said elongated handle has a grip surface.

### Claim 7

(canceled)

### Claim 8 (depends on 2)

The cartilage cutter of claim 2, wherein said elongated handle may be removably attached to said head region.

### Claim 9

(canceled)

### Claim 10 (depends on 2)

A kit of parts comprising the cartilage cutter of claim 2.

### Claim 11

A method for optimal implantation of a solid substrate for promoting cell or tissue growth or restored function for the treatment of osteoarthritis, bone disorders, osteochondral defects, or cartilage lesions in a subject in need thereof, said method comprising:
selecting and preparing a solid substrate for the treatment of or promoting cell or tissue growth or restored function for stable implantation in a region traversing bone and cartilage in a subject, which solid substrate has a length and width or that promotes a tight fit within the boundaries of the implantation site and is further characterized by a height sufficient such that when a first terminus of said solid substrate is implanted within bone in a site for implantation, a second terminus of said solid substrate is at a height at least 2 mm less than an articular cartilage layer surface or proximal to a tide mark region in said implantation site;
implanting said selected and prepared solid substrate within a site for implantation to span a basal to apical long axis of said site for implantation, wherein a first terminus of said implant is implanted within bone at the basal surface and a second terminus is oriented apically such that said second terminus is at a height at least 2 mm less than an articular cartilage layer surface or is proximal to a tide mark region in said implantation site such that a void is formed between an apical surface of said substrate and an articular cartilage layer; and optionally
applying a biocompatible polymer layer or hydrogel or therapeutic compound or cell population or combination thereof, to an apical surface of said implant to fill said void formed between said second terminus and said articular cartilage layer surface.

### Claim 12 (depends on 11)

The method of claim 11, wherein said solid substrate has a height of between 1-20 mm.

### Claim 13 (depends on 11)

The method of claim 11, wherein said solid substrate has a diameter of about 1-50 mm.

### Claim 14 (depends on 11)

The method of claim 11, wherein said solid substrate is further characterized by tapered sides.

### Claim 15 (depends on 14)

The method of claim 14, wherein said solid substrate is further characterized by comprising tapered sides at an angle of from 0.75 to about 4 degrees from a longitudinal axis along said solid substrate.

### Claim 16 (depends on 15)

The method of claim 15, wherein said tapered sides are at an angle of about two degrees from a longitudinal axis along said solid substrate.

### Claim 17 (depends on 11)

The method of claim 11, wherein said solid substrate is characterized by a conical or pyramidal frustum shape and optionally assumes a general shape of a bar, a plate, a cube, a cylinder, a cone or a screw.

### Claim 18 (depends on 11)

The method of claim 11, wherein said solid substrate comprises a coral or coral derivative, including essentially aragonite, calcite, hydroxyapatite or a combination thereof.

### Claim 19 (depends on 18)

The method of claim 18, wherein said solid substrate is characterized by a specific fluid uptake capacity value of at least 75% or is characterized by having a contact angle value of less than 60 degrees, when in contact with a fluid.

### Claim 20 (depends on 19)

The method of claim 19, wherein said establishing a specific fluid uptake capacity value of said solid substrate comprises the step of contacting said solid substrate with a fluid for from 0.1-15 minutes, allowing for spontaneous fluid uptake of said fluid within said solid substrate to arrive at said spontaneous fluid uptake value.

### Claim 21 (depends on 19)

The method of claim 19, wherein said establishing a specific fluid uptake capacity value of said solid substrate further comprises the step of contacting said solid substrate with a fluid and applying negative pressure to said solid substrate to promote maximal uptake of said fluid within said solid substrate to arrive at a total fluid uptake value.

### Claim 22

(canceled)

### Claim 23 (depends on 19)

The method of claim 19, wherein said fluid is a biologic fluid or a blood analog or a synthetic blood analog.

### Claim at position 24

-26. (canceled)

### Claim 27 (depends on 19)

The method of claim 19, wherein said fluid is water.

### Claim 28

(canceled)

### Claim 29 (depends on 18)

The method of claim 18, wherein said solid substrate is isolated from enriched coral.

### Claim 30 (depends on 11)

The method of claim 11, wherein said solid substrate comprises a hollow or hollows along a Cartesian coordinate axis of said solid substrate.

### Claim 31 (depends on 30)

The method of claim 30, wherein said hollow or hollows are along an axis substantially spanning from said second terminus toward said first terminus.

### Claim 32 (depends on 30)

The method of claim 30, wherein said hollow or hollows are along an axis extending from said second terminus up to half the height of said solid substrate, toward said first terminus.

### Claim 33 (depends on 30)

The method of claim 30, wherein said hollow or hollows are along an axis extending from said second terminus up to 30% of the height of said solid substrate, toward said first terminus.

### Claim at position 32

-37. (canceled)

### Claim 38 (depends on 11)

The method of claim 11, wherein said solid substrate has an overall shape that is ovoid or ellipsoid.

### Claim 39 (depends on 11)

The method of claim 11, wherein said solid substrate comprises an oval contour.

### Claim 40 (depends on 11)

The method of claim 11, wherein said implanting is conducted at an implant angle of from about 0.75 to about 4 degrees from an axis perpendicular to the surface of the tissue site being thus treated.

### Claim 41 (depends on 40)

The method of claim 40, wherein said implanting is conducted at an implant angle of from about 2 degrees from an axis perpendicular to the surface of the tissue site being thus treated.

### Claim 42

(canceled)

### Claim 43 (depends on 11)

The method of claim 11, wherein said method further comprises the step of contacting said solid substrate with cells or tissue or tissue derivatives or blood or blood derivatives pre-operative, intra-operative or post-operative.

### Claim at position 39

-45. (canceled)

### Claim 46 (depends on 11)

The method of claim 11, wherein said solid substrate promotes cell or tissue growth or restored function in tissue of a subject afflicted with a defect or disorder or disease of the cartilage or bone or a combination thereof.

### Claim 47 (depends on 46)

The method of claim 46, wherein said cartilage defect or disorder or disease comprises a full or partial thickness articular cartilage defect; osteochondral defect; osteoarthritis, avascular necrosis; osteochondritis dissecans; bone cyst, non-union fractures, fracture, bone defect, bone edema, osteoporosis, a joint defect or a defect resulting from trauma, sports, or repetitive stress.

### Claim 48 (depends on 47)

The method of claim 47, wherein said method serves to delay or eliminate the need for full or partial joint replacement in an affected subject.

### Claim 49 (depends on 48)

The method of claim 48, wherein said method serves to resurface an affected joint in a subject.

### Claim 50 (depends on 11)

The method of claim 11, wherein said method may be accomplished via automated systems for both preparation and implantation of said solid substrate.

### Claim 51 (depends on 50)

The method of claim 50, wherein said automated system may make use of robotic systems.

### Claim 52 (depends on 11)

The method of claim 11, wherein said method may provide an optimal customized implant and implantation based on pre-operative imaging and intra-operative findings.

### Claim at position 47

-92. (canceled)
